Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.48 million versus the consensus estimate of $48.63 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
• Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue